SecBot SecBot
144 ·Filed Jun 18, 2026

MRNA

Moderna, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001959173-26-004772
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a small sale by a former director. Monitor whether the sale actually executes, but no material read-through for MRNA stock. The insider's status as a former director reduces signaling significance.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$63.96
T+0 close · Jun 18, 2026 · via day close
Latest settled
+129.35%
T+60 · $146.69
Vs SPY
+127.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $63.96entry
  2. T+1 · 5mo ago −7.22%α −6.90% · $59.35
  3. T+5 · 5mo ago −6.58%α −4.92% · $59.75
  4. T+20 · 4mo ago −1.27%α −1.80% · $63.15
  5. T+60 · 2mo ago +129.35%α +127.45% · $146.69
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former director Paul Sagan filed a Form 144 notice of intent to sell 25,770 shares of Moderna common stock, valued at approximately $1.66 million, acquired via stock option exercise. The proposed sale is small relative to Moderna's $24.5B market cap and represents a routine insider transaction with limited signaling value.

Key Facts

  • Former director Paul Sagan filed Form 144 to sell 25,770 shares of MRNA common stock.
  • Estimated market value of proposed sale: $1,663,874.56.
  • Shares were acquired through a stock option exercise on the same date (06/18/2026).
  • Sale represents ~0.007% of Moderna's $24.5B market cap.
  • Only one other insider sale ($2.7M) was reported in the prior 30 days.

Financial Impact

Proposed sale of ~$1.66M, negligible relative to $24.5B market cap.

dilution

Risk Factors

  • No material risks identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
13% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004772
Document: 0001959173-26-004772-index.html0001959173-26-004772
Document: 0001959173-26-004772.txt0001959173-26-004772

Track record

26 reports on MRNA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +14.15% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 3/10 Entry $217.29 Now $215.27 −0.93% settles Nov 17
  2. Nov 13, 20263d ago 8-K Neutral 3/10 Entry $222.50 Now $215.27 −3.25% settles Nov 17
  3. Nov 6, 202610d ago 8-K Bullish 7/10 Entry $254.19 to $269.00 Now $215.27 −15.31% ▲ +5.83% +3.46% vs SPY
  4. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $241.46 to $254.19 Now $215.27 −10.85% ▲ +5.27% +4.96% vs SPY
  5. Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $214.17 to $222.76 Now $215.27 +0.52% ▲ +4.01% +4.40% vs SPY
  6. Oct 27, 202620d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $207.97 to $214.17 Now $215.27 −3.51% ▼ −2.98% −2.63% vs SPY
  7. Sep 30, 20266w ago 8-K Neutral 3/10 Entry $192.57 to $188.94 Now $215.27 +11.79% ▼ −1.89% −2.06% vs SPY
  8. Sep 30, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
  9. Sep 16, 20268w ago Insider Cluster Bearish 5/10 Entry $158.07 to $154.04 Now $215.27 −36.19% ▲ +2.55% +2.43% vs SPY
  10. Sep 3, 202610w ago ANALYST-DOWNGRADE Bearish 6/10 Entry $148.87 to $145.55 Now $215.27 −44.60% ▲ +2.23% +1.84% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026